CDK1 and central nervous system cancer: Western blot results revealed that following β-sitosterol treatment, the levels of cyclin B1 and CDK1 were reduced, and the effect was concentration dependent (Figure 3C–H), indicating that β-sitosterol induced G2/M phase arrest in glioma cells.